OvaScience announces plans to price public offering of common stock

Leerink Partners is the bookrunner; H.C. Wainwright also will assist

By Devika Patel

Knoxville, Tenn., May 25 – OvaScience, Inc. said it will price a public offering of common stock with a 30-day greenshoe.

Leerink Partners, LLC is the bookrunner. H.C. Wainwright & Co. is the co-manager.

Longwood Fund III LP has indicated an interest in investing about $5 million.

Proceeds will be used for the commercial expansion of the AUGMENTSM treatment, pre-commercial activities and working capital and other general corporate purposes.

Based in Cambridge, Mass., OvaScience is a fertility company focused on new treatments for infertility.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.